Saturday 17 October 2026
Export HSTM’s income statement to Excel — free account
HealthStream, Inc.
HSTM Healthcare Health Information Services
HealthStream, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $304.1 million, up 4.26% from fiscal 2024. In the quarter to June 2026, revenue grew 12.6%, EPS grew 27.8% and free cash flow grew 362.7%, each against the same quarter a year earlier. Dividend growth for three consecutive years, revenue growth for five.
33.13
0.62
−1.84%
Follow HSTM
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
41.53 | 37.82 | 30.91 | 37.85 |
P/S ratio |
2.81 | 2.28 | 1.95 | 2.48 | |
P/FCF ratio |
14.55 | 11.60 | 10.13 | 11.40 | |
P/Operating CF |
46.50 | 52.50 | 22.42 | 59.30 | |
P/B ratio |
2.40 | 1.96 | 1.73 | 2.23 | |
Price to Tangible BV |
7.47 | 9.68 | 8.04 | 9.49 | |
EV/Sales |
2.59 | 2.18 | 1.83 | 2.36 | |
EV/EBITDA |
9.92 | 8.69 | 7.10 | 9.04 | |
EV/Operating CF |
12.63 | 10.48 | 8.99 | 10.56 | |
EV/FCF |
13.43 | 11.12 | 9.49 | 10.85 | |
Quick Ratio |
1.12 | 0.77 | 0.81 | 0.84 | |
Current Ratio |
1.31 | 0.96 | 0.97 | 1.06 | |
Net Debt/EBITDA |
(4.29) | (3.38) | (3.00) | (2.88) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.60 | 0.59 | 0.59 | 0.63 | |
Operating CF/Net income |
2.96 | 5.20 | 4.59 | 2.01 | |
Capex/Depreciation |
(0.01) | (0.01) | (0.05) | (0.06) | |
Research and Development Expense of Revenue |
15.83% | 18.51% | 16.76% | 16.22% | |
Selling, General and Administrative Expense of Revenue |
25.46% | 28.43% | 25.81% | 25.72% | |
Intangible Assets out of Total Assets |
0.47 | 0.54 | 0.52 | 0.52 | |
Share Based Compensation of Revenue |
1.04% | 6.79% | 1.61% | 1.32% | |
Graham Net Nets |
0.00 | (0.07) | (0.07) | (0.04) | |
Graham Number |
13.41 | 12.72 | 13.44 | 14.06 | |
Earnings Yield |
2.41% | 2.64% | 3.24% | 2.64% | |
Free Cash Flow Yield |
6.87% | 8.62% | 9.87% | 8.77% | |
Revenue per Share |
2.58 | 2.66 | 2.76 | 2.86 | |
Operating CF per Share |
0.61 | 0.44 | 0.92 | 0.46 | |
Capex per Share |
0.00 | (0.01) | (0.03) | (0.03) | |
Free Cash Flow per Share |
0.60 | 0.43 | 0.90 | 0.43 | |
Cash per Share |
3.12 | 1.90 | 2.26 | 2.28 | |
Shareholders Equity per Share |
11.76 | 11.79 | 11.98 | 12.20 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
11.76 | 11.79 | 11.98 | 12.20 | |
Free Cash Flow |
17.92 | 13.03 | 26.40 | 12.52 | |
Working Capital |
35.08 | (4.49) | (3.49) | 7.59 | |
Capital Expenditures |
(0.11) | (0.16) | (0.74) | (0.91) | |
Net Current Asset Value |
(3.16) | (46.69) | (42.43) | (34.77) | |
EV/EBIT |
34.36 | 32.79 | 24.39 | 29.37 | |
Capex to Sales |
0.00 | 0.00 | 0.01 | 0.01 | |
Price to Operating Income |
37.23 | 34.22 | 26.03 | 30.87 | |
| Other line items | |||||
Average Receivables |
32.70 | 37.16 | 39.77 | 34.14 | |
Average Payables |
4.18 | 7.20 | 4.13 | 5.43 | |
Average Assets |
501.38 | 515.57 | 525.74 | 510.87 | |
Average Common Equity |
352.34 | 356.69 | 357.40 | 353.59 |
Columns are period end dates